Frontlight ResearchEarly access
Trial site
Tianjin Central Hospital of Gynecology Obstetrics
- 4running trials
- 2closed trials
The trials here
What the 6 trials at this site are about, from their registry records.
- Conditions
- Endometrial cancer2 trials
- Cervical cancer1 trial
- Gestational diabetes1 trial
- Ovarian cancer1 trial
- Uterine fibroids1 trial
- Phase
- Phase 33 trials
- Phase 21 trial
- Status
- Active, not recruiting1 trial
- Completed1 trial
- Enrolling by invitation1 trial
- Not yet recruiting1 trial
- Recruiting1 trial
- Terminated1 trial
- Lead sponsor
- Chia Tai Tianqing Pharmaceutical Group Co., Ltd.2 trials
- Bayer1 trial
- BeiGene1 trial
- Peking Union Medical College Hospital1 trial
- Tianjin Central Hospital of Gynecology Obstetrics1 trial
Running trials
Recruiting
Enrolling by invitation
Early Prediction of Gestational Diabetes in High-risk Women Based on Breath Metabolomics
Not yet recruiting
Anlotinib Hydrochloride Capsules Combined With TQB2450 in the Treatment of Endometrial Cancer
Active, not recruiting
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Cervical cancer1 recruiting
- Endometrial cancer1 recruiting
- Gestational diabetes1 recruiting
Closed trials
Site data: ClinicalTrials.govUpdated 15 Nov 2026